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An animal model of nociception involving unilateral hindpaw inflammation has been used to examine behavioral, molecular, and biochemical aspects of well-characterized spinal cord neural circuits involved in pain transmission.
The neurotoxin capsaicin administered neonataiiy was used to modify this neuronai system by producing a selective destruction of most small, unmeyiinated primary afferent axons. Capsaicin had minimal effects on the behavioral hyperaigesia and edema associated with the hindpaw inflammation and on the constitutive expression of preprodynorphin (PPD) mRNA and preproenkephalin mRNA in the spinal cord. However, the inflammation-induced increases in Fos-like immunoreactivity (Fos-Li) and in PPD mRNA were greatly attenuated by neonatal capsaicin treatment. The data indicate that input from small-diameter unmyellnated primary afferents is important for the stimulus-induced increase in FosLi and PPD mRNA. Our finding that neonatal capsaicin reduces the levels of Fos-LI and PPD mRNA in a related fashion in the spinal dorsal horn provides further evidence for a relationship between the protein product of the c-fos protooncogene and regulation of dynorphin gene transcription.
Subcutaneous injection of a chemical irritant, complete Frcund's adjuvant (CFA), can be used to induce unilateral hindpaw edcma and thermal hyperalgesia of prolonged duration (Hargreaves et al., 1988; Iadarola et al., 1988b ). This animal model of nociception permits us to make observations relevant to the function of a well-characterized neuronal pathway and to the processes involved in neuronal plasticity in general. More importantly, it offers a unique opportunity to examine the molecular, biochemical, physiological, and behavioral events of nociception. The noxious stimulation resulting from CFA injection has been shown to induce the expression of the protooncogene c-fos as well as expression of Fos or Fos-related proteinlike immunoreactivity (Fos-LI) (Hunt et al., 1987; Menttrey et al., 1989; Presley et al., 1990; Noguchi et al., 199 1, 1992) . The protein products of protooncogenes such as c-fos appear to function as transcription fac-tors that bind to DNA or to DNA-binding proteins to regulate transcription (Curran and Morgan, 1987; Morgan and Curran, 1989; Sheng and Greenberg, 1990) . Unilateral hindpaw inIlammation also induces an increase in the expression of spinal cord opioid gene mRNAs and the resultant peptides (Iadarola et al., 1988a,b; Millan et al., 1988; Ruda et al., 1988; Noguchi et al., 1989) . Neurons with increased levels of preprodynorphin (PPD) mRNA (Ruda et al., 1988; Noguchi et al., 199 1) and preproenkephalin (PPE) mRNA (Noguchi et al., 1989 (Noguchi et al., , 1992 are located predominantly in laminae I-II and V-VI, as are neurons with Fos-LI. The majority of neurons exhibiting an increase in either PPD or PPE mRNA after inflammation also colocalize Fos-LI (Noguchi et al., 199 la, b) . These data suggest that a relationship may exist between the induction of Fos and Fos-related proteins and the subsequent regulation of opioid gene expression in the spinal cord following peripheral stimulation. Capsaicin is a neurotoxin that, when administered to neonatal rats, results in the destruction of a large subpopulation of smalldiameter, mainly unmyeiinated primary afferents. These unmyeiinated axons include subpopulations that contain the peptides substance P (SP) and calcitonin gene-related peptide (Skolitsch and Jacobowitz, 1985; Buck and Burks, 1986; Hammond and Ruda, 1989, 199 1; Kashiba et al., 1990) . We have used neonatal capsaicin treatment as a tool to destroy a population of primary afferents, most of which convey nociceptive inputs to the spinal cord, and have examined the resultant effect on the production of inflammation-induced edema, hyperalgesia, and the induction of Fos protein and PPD mRNA in the spinal cord. Our observations demonstrate that edema and comparable levels of hyperalgesia can be produced in animals that lack the majority of their unmyelinated primary afferent axons. However, the induction of Fos protein and PPD mRNA seen in control animals with inflammation-induced hyperalgesia is greatly attenuated in neonatal capsaicin-treated rats.
(proximal to) the pads. Initiation of a trial by turning on the light source also activated a timer. The timer and heat source were automatically turned off when a change in reflected light was detected by a photocell (Hargreaves et al., 1988 ). An upper cutoff latency of 20 set was imposed to prevent tissue damage. Control rats with noninflamed paws have been shown to withdraw their paws at a temperature of approximately 4X, whereas inflamed paws were withdrawn at about 39°C (Hargreaves et al., 1988) . The paw withdrawal latency was recorded to the nearest 0.1 sec. Testing was repeated for each paw at greater than 2 min intervals. The mean of two trials was used for subsequent analysis. Behavioral data were obtained from 36 rats (12 vehicle treated and 24 capsaicin treated).
Variability in the literature with respect to the hypoalgesic effect of capsaicin treatment may depend on both the nature of the nociceptive test, the age of the animal at the time of treatment, and the length of time between treatment and testing (Hammond and Ruda, 199 1) . We have tested our animals at a time when the capsaicin effects on thermal responses are maximal (5-8 weeks) and have used a slowly rising thermal pulse as a stimulus. The withdrawal latency in this paradigm can be correlated to nociceptive detection threshold. Our testing method differs from that described bv Doucette et al. (1987) . who used a hot probe at superthreshold temperature (65-70°C) Bpplied to the glabrous skin of the paws of capsaicin-treated and control rats. Our testing procedure has given reliable and reproducible results and has proven to be an easily quantifiable method for assessing unilateral hyperalgesia, a condition that is typically characterized by more integrative responses such as limb guarding, hyperreflexia, and paw licking. riumlml ofemulsion) into the plantar surface of one hindpaw at 8 weeks of aae. CFA iniection into the hindnaw nroduces localized inflammaInduction'of hindpaw inflammation and behavioral testing. All rats were given a subcutaneous injection of 0.2 ml of complete Freund's adjuvant (CFA, Mycobacterium tuberculosis; Sigma) suspended in an oil : saline (1: 1) emulsion (at a concentration of 0.5 mg of Mvcobactepresence of 0.01% hydrogen peroxide (6-12 min). Tissue sections were then washed in PBS, mounted on slides, dried, and coverslipped. The epitope recognized by the Fos antibody is from the conserved region of the protein and is present in Fra-1, Fra-2, and Fos B as well as Fos . Therefore, the antibody may have recognized these other proteins that may also be involved in gene transcription. Fos-LI observed in these experiments has therefore been referred to as indicating the presence of Fos or Fos-related proteins. Tissue sections from the same animals that were used for determination of Fos-LI were examined for the degree of SP staining.
Neurons with Fos-LI in their nuclei ipsilateral and contralateral to inflamed hindpaws were counted in randomly selected tissue sections (N = 2-3 rats per treatment group at each time point, 10-20 sections per rat). Pairwise comparison (t test) was used to determine ipsilateral versus contralateral differences in each animal. An analysis of variance compared the number of Fos-like immunoreactive nuclei ipsilateral to the inflamed hindpaw (mean number of nuclei per section in each animal) in the capsaicin-treated versus the vehicle-treated groups at 2, 6, 24, and 48 hr. p < 0.05 was considered significantly different.
In situ hvbridization. For in situ hvbridization histochemistry, tissue sections from rats 4 d after unilateralCFA hindpaw injection were used. Transverse 2 1 pm sections from the L4 segment were cut with a cryostat, thaw mounted onto Vectabond (Vector Lab. Inc.)-coated slides, and stored at -80°C until ready to use.
To begin the in situ hybridization, tissue sections were digested with oroteinase K (1 ma/ml. 37°C. for 30 min: Sigma) in 0.1 M Tris. 0.05 M 4x salin&sodium citrate (SSC, 1 x SSC = 0.15 mM NaCl, 0.015 mM ethylenediaminetetra-acetic acid (pH 8.0); rinsed briefly in distilled water; followed by 0.1 M triethanolamine (TEA) (pH 8.0); acetylated with sodium citrate). 50% formamide, 0.12 M phosphate buffer; 1 x Den-0.25% acetic anhydrate in 0.1 M TEA (pH 8.0); and dehydrated through graded ethanols. The hybridization was performed overnight at 37°C with lo6 dpm of labeled probe/l00 ~1 buffer/slide. The buffer contained tionyas characterized by erythema, edema, and hyperalgesia, that peaks at 6-24 hr after injection and lasts more than 5 d (Iadarola et al., 1988a; Hylden et al., 1989) . Thermal nociceptive testing using the methods described above was repeated in groups of rats at 2, 6, 24, and 48 hr. Edema was estimated by measuring dorsal-plantar paw diameter with a vernier caliper. Rats with unilateral hindpaw inflammation demonstrate normal eating and grooming behavior and normal levels of locomotor activity (Iadarola et al., 1988a ) but tend to guard the inflamed paw. In order to minimize any discomfort, rats were housed in cages containing soft sawdust bedding and the number of animals used was kept to a minimum. This model of unilateral inflammation has been approved by the National Institute of Dental Research Animal Care and Use Committee and conforms to the guidelines of the International Association for the Study of Pain (Zimmermann, 1983) .
Paw withdrawal latency and paw diameter data were combined for all litters tested. Significant main effects were determined by analysis of variance. A p value of less than 0.05 was taken to indicate significance. The investigator was blind with respect to treatment group during behavioral testing.
Immunocytochemistry. Representative rats from each treatment group were deeply anesthetized immediately after behavioral testing at each time point (four to six rats at 2, 6, 24, and 48 hr) and perfused through the heart with 4% parafotmaldehyde in 0.1 M phosphate buffer (pH 7.4). Spinal cords were removed, postfixed overnight in cold fixative, and subsequently stored in cold phosphate-buffered saline (PBS). Following cryoprotection in 30% sucrose, 24 pm transverse sections were cut from the lumbar enlargement on a cryostat. Tissue sections from the L4 lumbar segment were used for analysis of Fos-immunoreactive nuclei. Sections from other lumbar segments were used for analysis of SPimmunoreactive fibers. Tissue sections from capsaicin-and vehicletreated littermates were processed simultaneously under identical conditions.
Immunocytochemical staining was done using the peroxidase-antiperoxidase (PAP) method (Stemberger, 1979) as previously described by Ruda et al. (1982) . Tissue sections were incubated in polyclonal antiserum to Fos and Fos-related proteins (1:250; generously provided by Dr. M. J. Iadarola et al., 1989) or SP (1:7000; Incstar) for 48 hr at 4°C with gentle agitation, followed by incubation in secondary antiserum (goat anti-rabbit IgG, 1:200; Accurate) for 60 min at room temperature. Following incubation in rabbit PAP (1:3000, 60 min at room temperature), the sections were rinsed in two changes of PBS and reacted with 0.05% 3,3'-diaminobenzidine tetrahydrochloride in the hardt's solution, 0.2% sodium dodecyl sulfate, 250 mg/ml yeast tRNA, 10% dextran sulfate, and 100 mM dithiothreitol. The oligonucleotide probes (Synthecell Corp.) consisted of 48 bases complementary to either bases 862-909 of the PPD mRNA sequence (Civelli et al., 1985) or bases 512-559 of the PPE mRNA sequence (Yoshikawa et al., 1984) . The purified probes were labeled with YS-deoxyadenosine [a-thio] triphosphate (New England Nuclear) to a specific activity of 5-10 x 10' Ci/mmol. Followinghybridization, the sections were washed four times for 15 min each at 55°C in 1 x SSC. followed bv a wash in 1 x SSC at room temperature for 30 min, rinsed'in distilled water briefly, and dried. The specificity of the probes and hybridization reaction were verified as described previously (Young et al., 1986; Ruda et al., 1988: Draisci and Noguchi et al., 1992) . In addition, RNA blot analysis of spinal cord tissue using the oligonucleotide probes yielded a single band at the appropriate molecular weight.
For autoradiography, the tissue sections were coated with Kodak NTB3 emulsion (diluted 1: 1 with distilled water at 40°C) and exposed for 2-6 weeks in light-tight boxes at 4°C. After development in D 19 (Kodak) and fixing in 24% sodium thiosulfate, the sections were rinsed in distilled water, stained with neutral red, and coverslipped. We quantified the change of PPD mRNA by counting all labeled cells on 12 tissue sections taken from the L5 level of two control and two capsaicintreated rats. The total number of PPD mRNA-nositive neurons in superficial or deep dorsal horn laminae was recorded on the sides ipsilateral and contralateral to the inflammation. To facilitate the quantification, neurons with grain densities at 10 times higher than background were considered positively labeled for PPD mRNA. Since our background labeling was low (1.8 grains/l0 mm*), this high signal-tonoise ratio effectively eliminated from our counts dorsal horn neurons with low constitutive levels of expression especially on the side contralateral to the inflammation, and emphasized the number of neurons that had increased levels of PPD mRNA expression.
Results

Edema and hyperalgesia in capsaicin-and vehicle-treated rats
Behavioral responsitivitv to nocicentive stimulation was tested between 5 and-8 weeks df age usinga noxious thermal stimulus applied to the plantar surface of noninflamed hindpaws of capsaicin-and vehicle-treated rats. Capsaicin-treated rats responded to the noxious thermal stimulus although they exhibited Age (weeks) Figure 1 . Paw withdrawal latency ofcontrol and capsaicin-treated rats at 5-8 weeks of age. Data are from six litters treated at postnatal day 2 with capsaicid(N = 24 rats; friungfes) or vehicle (N = 12 rats; circles). *, Capsaicin-treated rats had significantly elevated withdrawal latencies over this 5-8 week time course @ < 0.00 1, ANOVA). Error bars represent I SEM.
significantly longer paw withdrawal latencies than did their vehicle-treated litter-mates (Fig. I) . Between 5 and 8 weeks of age, capsaicin-treated rats had weekly average paw withdrawal latencies of II.6 to 14.5 set while control rats had average paw withdrawal latencies of 9.2-10.4 set at 5-8 weeks.
At 8 weeks ofage, edema was produced by unilateral injection of CFA into one hindpaw of both capsaicin-and vehicle-treated rats. The time course of the development of the edema and its resolution was the same in capsaicin-treated and control rats, as measured by paw diameter 2 hr to 7 d after injection of CFA (Fig. 2) . The peak response occurred at 24 hr. The injected hindpaw also became hyperalgesic in both capsaicin-and vehicle-treated rats (Fig. 3) . Inflammation was accompanied by a rapid decrease in paw withdrawal latency that was maximal at 6 hr after CFA injection in both treatment groups (Fig. 3) . In capsaicin-treated rats, inflamed paws had a baseline average value of I I.8 set and a low of 5.9 set at 6 hr (net decrease, 5.9 XC). Paw withdrawal latencies were still significantly decreased in both treatment groups at 24 and 48 hr. The net decrease in withdrawal latency of the inflamed paw in capsaicin-treated rats was 5.9 set, whereas the net decrease in withdrawal latency of the inflamed paw in the vehicle-treated rats was 5.0 sec. When the latency data from inflamed hindpaws were analyzed using ANOVA, the treatment versus time interaction term was found not to be significant. Thus, the time course and magnitude of hyperalgesia were similar for capsaicin-treated and control animals. Contralateral noninflamed hindpaws showed no change in withdrawal latency in either group.
Distribution of Fos-like immunoreactive nuclei
The Fos-LI in spinal cord neurons was restricted to the cell nucleus (Fig. 4) . In capsaicin-treated rats, a slight increase in the number of labeled nuclei was detected ipsilateral to the inflamed hindpaw in laminae I and II at all time points studied as compared to the contralateral noninflamed hindpaw. However, the difference was only statistically significant at 6 hr (see Fig. 6 ). The labeled nuclei were concentrated in the medial twothirds of the superficial laminae, a region of the L4 segment that received direct input from the inhamed hindlimb (Fig. 5 ). The deeper laminae had few nuclei exhibiting induction of Fos-LI, and the ipsilateral versus contralateral difference in labeled nuclei was statistically significant only at the 48 hr time point (Fig.  6 ). By contrast, in vehicle-treated rats, the unilateral hindpaw Figure 4 . Photomicrographs of transverse tissue sections from the I.4 lumbar segment of a capsaicin-treated rat (A and B) and a control rat (C and D) that were stained for Fos-LI. These sections were obtained from rats that were perfused at 6 hr after unilateral injection of CFA. The superficial dorsal horn ipsilateral to inflammation is shown in A and C and contralateral to inflammation is shown in B and D. Note the abundance of Fos-labeled nuclei in laminae I and II just under and medial to the dorsal root entry zone ipsilateral to inflammation in the section from the control rat (C) and attenuation of the number of Fos-LI nuclei in the capsaicin-treated rat (A). Scale bar, 50 Wm.
inflammation produced a dramatic induction of Fos-LI in the dorsal horn on the injected side as compared to the contralateral side (Fig. 4) . In the superficial laminae, the increase in labeled nuclei on the inflamed, side was statistically significant at all time points studied and was maximal at 6 hr (Fig. 6 ). In the deeper laminae, there was a statistically significant increase at all time points but the peak effect was delayed compared to the superficial laminae, occurring at 24 hr. Thus, capsaicin treatment appeared to decrease induction of Fos-LI markedly and only transient significant increases were seen at isolated time points. Few labeled nuclei were found in the spinal dorsal horn contralateral to the inflammation in both capsaicin-treated and vehicle-treated rats (Fig. 6 ).
Distribution of PPD neurons
In neonatal capsaicin-treated rats, in situ hybridization revealed a few neurons in the superficial laminae and neck of the dorsal horn ipsilateral to the inflammation with increased PPD mRNA (Fig. 7A ) compared to the low constitutive expression on the contralateral side (Fig. 7B) . However, there were fewer cells with a detectible upregulation of PPD mRNA than that observed in vehicle-treated animals with an inflamed hindpaw (Fig. 70 .
Although there was variability in the number of neurons with high levels of PPD mRNA expression in individual sections, the superficial dorsal horn laminae in capsaicin-treated rats overall had an 82% reduction in the number of labeled neurons compared to vehicle-treated rats (Table 1 ). In the deep dorsal horn laminae of capsaicin-treated rats, there was a 50% reduction in neurons that exhibited increased PPD mRNA compared to vehicle-treated rats (Table 1) . Numbers represent the total number of PPD mRNA-labeled neurons with a signalto-noise ratio of > 10 from 12 sections of two capsaicin-treated or two control rats at 3 d after induction of inflammation. Distribution of PPE neurons PPE mRNA expression was used to determine whether neonatal capsaicin treatment would result in a generalized alteration in spinal cord gene expression. Eight-week-old rats, neonatally treated with capsaicin, displayed a high level of constitutive PPE mRNA expression in the spinal cord (Fig. %I) . Labeled neurons were found in all laminae of the dorsal horn as well as the ventral horn excluding motoneurons. Taking into account section-to-section variability in labeling due to the individual components of the neuropil, in situ hybridization suggests that there was no significant difference in labeling of PPE mRNA in control and neonatal capsaicin-treated rats (compare Fig. 8A .B).
Since previous studies in our laboratory have shown only a small effect of inflammation-induced hyperalgesia on PPE mRNA expression, we did not analyze spinal cord sections for changes in PPE mRNA in capsaicin-treated animals with an inflamed hindpaw.
SP immunoreactivity in capsaicin-and vehicle-treated rats As a control for the efficacy of capsaicin treatment, tissue sections were examined for SP labeling. Although SP in the dorsal horn may originate from either primary afferent axons, intrinsic dorsal horn neurons, or axons descending from neurons in the brainstem, a major component is C-fiber primary afferents. All capsaicin-treated rats had significant decreases in SP immunoreactivity in both the superficial laminae and the neck of the dorsal horn, areas in which small-diameter primary afferents terminate (Fig. 9) Figure 6 . Number of Fos-LI nuclei (mean per section) observed in superficial and deep laminae at 2-48 hr after injection of CFA in one hindpaw. A, Nuclei with Fos-LI were counted in the medial two-thirds of laminae I and II of randomly selected 24 Frn transverse sections from control rats and capsaicin-treated rats (N = 2 or 3 rats per treatment group at each time point, I O-20 sections were counted per rat). ANOVA comparing the two groups across time indicated a significant attenuation of Fos-LI ipsilateral to inflammation in the superficial laminae in the capsaicin-treated group (p < 0.001). Each control animal demonstrated a significant inllamed versus noninflamed difference at all time points (p < 0.05). Each capsaicin-treated rat only showed a significant increase in Fos labeling in the superficial laminac at 6 hr (p < 0.05). B, Fos-like immunoreactivc nuclei were also counted in laminae IV-VII and X of the same tissue sections included in A. Capsaicin treatment significantly attenuated Fos-LI ipsilateral to the inflammation in the deeper laminae (p < 0.001). Significant inflamed versus noninflamed differences (p < 0.01) occurred at all time points in each vehicle-treated animal, but only at 48 hr for each capsaicin-treated animal. CFA injection had no significant effect on the number of Fos-labeled nuclei observed contralateral to inflammation. Error bars represent I SEM.
cffccts ofcapsaicin on this neuropeptide at 8 weeks after neonatal capsaicin treatment (Hammond and Ruda 1989, 199 1) .
Discussion
Neonatal capsaicin treatment in rats was used to destroy most of the unmyclinated axons in peripheral nerves in order to evaluate the role of such afferents in behavioral hyperalgesia and in the expression of Fos-LI and dynorphin gene expression following peripheral tissue inflammation. We found that both the induction of Fos-LI and the enhanced expression ofPPD mRNA Figure 7 . Dark-field photomicrographs of sections of the L5 dorsal horn of neonatal capsaicin-treated (A and B) and control rats (C and D) following in situ hybridization with an 3SS-labeled PPD probe. At 4 d after inflammation, the sides ipsilateral to the inflammation (A and C) exhibit an increased density of silver grains overlying neurons in the superficial and deep laminae as compared to each treatment groups' side contralateral to the inflammation. However, the neuronal response is greatly attenuated in the capsaicin-treated rats (A) as compared to controls (c). Scale bar, 100 pm.
following inflammation appear to depend to a large extent on input from capsaicin-sensitive primary afferents. We conclude that increased activity of capsaicin-sensitive unmyelinated nociceptive afferents induced by the inflammatory agent CFA is primarily responsible for activation of the cellular immediateearly gene c-fos and the resultant effect of its protein product on target genes. Our finding that neonatal capsaicin treatment reduced the level of Fos-LI and PPD mRNA in a related fashion in the spinal dorsal horn further suggests that the protein product of the c-fos proto-oncogene may be involved in the regulation of dynorphin gene transcription.
It was important to demonstrate that capsaicin-treated and vehicle-treated rats developed similar signs of inflammation in the periphery in order to compare central changes in each group of animals. Capsaicin-treated rats were tested from 5 to 8 weeks of age to verify that the animals detected thermal stimuli and that their sensitivity to thermal stimuli was similar over this time period. The longer paw withdrawal latencies in capsaicintreated than in control rats confirmed previous findings that neonatal capsaicin results in a reduction in thermal sensitivity but does not abolish the response to noxious thermal stimuli Ruda, 1989, 1991) . The neurotoxic effect of neonatal capsaicin treatment, however, had a minimal effect on CFA-induced edema and thermal hyperalgesia. The injection of CFA produced similar levels of edema, and the time course and relative magnitude of hyperalgesia were similar in capsaicin-treated and vehicle-treated rats. Capsaicin treatment has long been known to block neurogenic inflammation (Jansco et al., 1977) , although the direct action of peptides to produce plasma extravasation IS not impaired (Gamse et al., 1980) . Thus, the peripheral inflammatory response to CFA injection does not appear to require capsaicin-sensitive neurogenic mechanisms.
We utilized changes in SP levels in the spinal cord to verify that neonatal capsaicin treatment had destroyed a subpopulation of unmyelinated primary afferents in the groups of rats used in this study. Tissue sections immunocytochemically stained for SP showed markedly decreased levels of this peptide at 8 weeks, consistent with its loss from primary afferents, but not from Figure 8 . Dark-field photomicrographs of sections of the L5 dorsal horn of neonatal capsaicin-treated (A) and control (B) rats following in situ hybridization with an %-labeled synthetic oligonucleotide probe complementary to PPE. Constitutive PPE expression continues at a high level after the capsaicin-induced loss of small-diameter primary afferent input to the spinal cord. Scale bar, 100 pm. intrinsic dorsal horn neurons or supraspinal descending axons (Ruda et al., 1986; Solodkin and Ruda, 1988) . This finding, in conjunction with the reduced thermal sensitivity of the rats at 2-8 weeks, provides evidence that the neonatal capsaicin treatment destroyed a large subpopulation of unmyelinated C-afferents, as previously reported (Nagy et al., 198 1) . Other studies in our laboratory have confirmed at the electron microscopic level a greater than 85% decrease in unmyelinated axons in the L5 dorsal roots of 8-week-old neonatal capsaicin-treated rats (M. A. Ruda, unpublished observations). Since myelinated afferents are relatively heat insensitive in the rat (Lynn and Shakhanbeh, 1988) , it is possible that the small number of unmyelinated primary afferent fibers that remain after capsaicin treatment are responsible for the observed thermal hyperalgesia.
Neonatal capsaicin treatment may result in changes in the dorsal horn related to the loss of unmyelinated afferents. Such central changes may involve functional deficits or actual cell death of some spinal neurons (Saporta, 1986) , altered excitability of spinal neurons (Wall et al., 1982; Cervero et al., 1984) , or other compensatory changes (Nagy and Hunt, 1983; Rtthelyi et al., 1986) . Although such changes did not appear to have an effect on the behavioral response of the animals to inflammation, it is possible that gene expression in the dorsal horn may have been altered. To address this issue, we examined Fos-LI and opioid gene expression under control conditions (no inflammation or noxious peripheral stimulation). Neonatal capsaicin treatment had no effect on the low constitutive expression of Fos-LI or PPD mRNA, or the high constitutive expression of PPE mRNA in the spinal cord. These data indicated that the capsaicin-induced loss of primary afferent axons in the spinal cord did not, of itself, alter the constitutive c-fos or opioid gene expression.
Several studies have demonstrated Fos activation in the spinal cord following noxious peripheral stimulation (Hunt et al., 1987; Bullitt, 1989 Bullitt, , 1990 Menttrey et al., 1989; Presley et al., 1990; Tolle et al., 1990; Wisden et al., 1990; Noguchi et al., 199 1, 1992) . The time course of Fos upregulation appears to depend on the nature of the stimulus (noxious chemical, heat, mechanical) and its duration. Our data from control rats agree with reports that a noxious stimulus produces a rapid increase in Fos-LI in the superficial dorsal horn (Hunt et al., 1987; Menktrey et al., 1989; Presley et al., 1990; Tolle et al., 1990; Wisden et al., 1990) , followed by a delayed increase in labeling in deeper laminae . This pattern of Fos activation produced by noxious peripheral stimulation is not present in capsaicin-treated animals. CFA induces in these animals small, transient changes in Fos activation that neither persist nor have a typical time course.
Fos and Jun are thought to bind at AP-1 sites in the promoter region of target genes and thereby regulate transcription. Protooncogenes such as c-fos have been proposed to play important roles in the ability of neurons to convert a short-term stimulus into complex, long-term responses such as those involved in memory or neuronal plasticity (Goelet et al., 1986) . The persistent changes in spinal cord excitability induced by peripheral tissue injury or stimulation of small-diameter afferents (Hylden et al., 1989; Woolf, 1989; Dubner, 199 1) may be related to such mechanisms. Increased activation of small-diameter primary afferents results in expansion of the receptive fields of spinal dorsal horn nociceptive neurons and an increase in their excitability. These changes lead to enhancement of nociceptive activity at supraspinal sites that may be perceived as an increase in pain (Dubner, 199 1; Hylden et al., 199 1) . Thus, the regulation of gene transcription by the protein products of proto-oncogenes such as c-fos may lead to long-term changes in spinal cord excitability and resulting persistent pain and hyperalgesia.
Peripheral tissue inflammation has also been shown to produce a robust increase in dynorphin peptide in the spinal cord (Iadarola et al., 1988a; Millan et al., 1988; Ruda et al., 1988) . This increase is preceded by an increase in the levels of PPD mRNA coding for this opioid peptide product (Iadarola et al., 1988a) . The role of dynorphin in the spinal cord processing of nociceptive stimuli is not clear. Dynorphin has been shown to have mixed effects on the excitability of dorsal horn neurons (Knox and Dickenson, 1987) and may contribute to the enhanced excitability of superficial dorsal horn neurons during conditions of peripheral inflammation (Hylden et al., 199 1) . Our present findings that the inflammation-induced increase in dynorphin gene expression is markedly attenuated by neonatal capsaicin treatment suggest that this upregulation is dependent on activity in capsaicin-sensitive primary afferents. Since neurons in the superficial dorsal horn exhibited expanded receptive Figure 9 . Photomicrographs of tissue sections from the lumbar spinal cord of a capsaicin-treated rat (A) and a control rat(B). These 24 pm transverse sections were immunocytochemically stained for SP. Neonatal capsaicin-treated rats exhibited a substantial depletion of SPlike immunoreactivity in the dorsal horn. Scale bar, 100 pm. fields and increased responsiveness to mechanical and thermal stimulation during peripheral inflammation (Hylden et al., 1989) , it would be of interest to determine if the attenuating effect of capsaicin treatment on inflammation-induced increases in dynorphin has a comparable effect on the physiological responsiveness of dorsal horn neurons.
In the spinal dorsal horn, the stimulus-induced upregulation of Fos-LI is correlated with an increase in the expression of PPD mRNA and PPE mRNA. Previous studies have shown that c-fos mRNA increases within 30 min following injection of an inflammatory agent and precedes increased PPD mRNA expression that is first observed at 4 hr . Whereas unilateral inflammation has been shown to produce a robust increase in dynorphin gene expression (Iadarola et al., 1988a,b; Ruda et al., 1988; Draisci and Iadarola, 1989; Noguchi et al., 1991) , relatively small increases in PPE mRNA were seen with RNA blot hybridization (Iadarola et al., 1988b; Draisci and Iadarola, 1989 ) and in situ hybridization (Noguchi et al., 1992) . Both PPD mRNA and PPE mRNA have been shown to increase within some spinal dorsal horn neurons that also exhibit increases in Fos-LI after inflammation (Noguchi et al., 199 1, 1992) . The majority (> 80%) of PPD mRNA-and PPE mRNA-positive neurons were also labeled for Fos-LI in their nuclei. This colocalization suggests that Fos plays a role in the regulation of opioid gene transcription. Our present findings that Fos-LI and PPD mRNA are attenuated in a similar fashion in capsaicin-treated rats provide further support to the hypothesis that these alterations in Fos activation and dynorphin gene expression are related events. Recently, an AP-1 like binding site in the promoter region of the rat prodynorphin gene has been shown to bind Fos and Jun proteins and to induce dynorphin gene transcription (Naranjo et al., 199 1) .
Our data suggest that a lack of Fos activation does not necessarily imply a lack of neuronal activation. Capsaicin-treated rats had an attenuated response in terms of the number of ncurons exhibiting Fos-LI, but these same capsaicin-treated rats did respond to noxious thermal stimuli and did develop thermal hyperalgesia. Thus, the small number of unmyelinated primary afferents remaining after neonatal capsaicin treatment may be sufficient for the behavioral response to inflammation. At the same time, this reduced number ofafferents may only bc capable of producing Fos activation in a restricted population of spinal cord neurons. The data suggest that activity in unmyelinated primary afferents is critical for the full expression of Fos activity in response to peripheral nociceptive inputs. The concomitant loss of many peptide-containing primary afferents following capsaicin treatment suggests that neuropeptides such as SP and calcitonin gene-related peptide participate in the initiation of synaptic events that lead to Fos and dynorphin gene activation.
In this study, we have seen that a selective destruction of small-diameter, mainly unmyelinated primary afferents can be a useful tool in examining the relationships between molecular, biochemical, and behavioral events that are relevant to spinal cord function. Our observations support a role for small-diameter unmeylinated primary afferents in the stimulus-induced upregulation of both Fos-LI and PPD mRNA. The attenuation of inflammation-induced increases in Fos-LI and PPD mRNA by neonatal capsaicin treatment provides further support for the role of Fos in dynorphin gene transcription in the spinal cord. These observations have important implications in our understanding of mechanisms of stimulus-dependent plasticity in the spinal cord.
